Plasma sCLEC-2 levels were significantly higher in patients with IFN, or thrombotic diseases, including MVT, ATE, and VTE, than in those with neither thrombotic diseases nor IFN, including those with ITP, ICS, or CLD. The gene discussed is IFNA1; the disease is autoimmune thrombocytopenic purpura.